
News|Articles|October 1, 2006
Infliximab
TNF inhibitor approved for inhibiting joint damage, improving physical function in psoriatic arthritis
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
7 things you need to know about the PBM reforms signed into law this week
2
Oral Wegovy, uACR test spotlighted in the health-oriented Super Bowl ads
3
A conversation about the consequences of Florida’s HIV medication cuts with Colleen Kelley, M.D., M.P.H., immediate past chair of the HIVMA and HIV specialist in Atlanta, Georgia
4
Immunotherapy levels survival differences between men and women with metastatic melanoma
5

























